You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

~ Buy the BUTYLPARABEN Drug Excipient Business Development Opportunity Report, 2024 PDF Report in the Report Store ~

Drugs Containing Excipient (Inactive Ingredient) BUTYLPARABEN

✉ Email this page to a colleague

« Back to Dashboard

Branded drugs containing BUTYLPARABEN excipient, and estimated key patent expiration / generic entry dates

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Dista Products Company	PROZAC	fluoxetine hydrochloride	0777-3104	BUTYLPARABEN
PharmaDerm a division of Fougera Pharmaceuticals Inc	PANDEL	hydrocortisone probutate	10337-153	BUTYLPARABEN
Sun Pharmaceutical Industries Inc	ULTRAVATE	halobetasol propionate	10631-122	BUTYLPARABEN
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Generic drugs containing BUTYLPARABEN excipient

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC	Excipient
L Perrigo Company	permethrin	0113-1910	BUTYLPARABEN
Pharmaceutical Associates Inc	ibuprofen	0121-4774	BUTYLPARABEN
Walgreen Company	ibuprofen	0363-0255	BUTYLPARABEN
>Company	>Ingredient	>NDC	>Excipient

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.